High Stakes Require More Than Just Talk: What to Do About Corruption in Health Systems; Comment on “We Need to Talk About Corruption in Health Systems”

Document Type : Commentary


School of Nursing and Health Professions, University of San Francisco, San Francisco, CA, USA


Reluctance to talk about corruption is an important barrier to action. Yet the stakes of not addressing corruption in the health sector are higher than ever. Corruption includes wrongdoing by individuals, but it is also a problem of weak institutions captured by political interests, and underfunded, unreliable administrative systems and healthcare delivery models. We urgently need to focus on corruption as a health systems problem. In addition to supporting research to better understand the context and implications of corruption in health systems, this article suggests actions that public health professionals can do now to fight corruption.


Main Subjects

  1. Hutchinson E, Balabanova D, McKee M. We need to talk about corruption in health systems. Int J Health Policy Manag. 2018;8(4):191-194. doi:10.15171/ijhpm.2018.123
  2. Bridoux J, Gebel A. Flexibility versus Inflexibility: discursive discrepancy in US democracy promotion and anti-corruption policies. Third World Q. 2012;33(10):1945-1963. doi:10.1080/01436597.2012.728323
  3. Werner C. Gifts, bribes, and development in post-Soviet Kazakstan. Hum Organ. 2000;59(1):11-22. doi:10.17730/humo.59.1.w2582tqj18v3880p
  4. Klitgaard R. Controlling Corruption. Berkley, CA: University of California Press; 1988.
  5. Klitgaard R, Maclean-Abaroa R, Parris HL. Corrupt Cities: A Practical Guide to Cure and Prevention. Oakland CA: ICS Press; 2000.
  6. Muldoon KA, Galway LP, Nakajima M, et al. Health system determinants of infant, child and maternal mortality: A cross-sectional study of UN member countries. Global Health. 2011;7:42. doi:10.1186/1744-8603-7-42
  7. Pinzon-Florez CE, Fernandez-Nino JA, Ruiz-Rodriguez M, Idrovo AJ, Arredondo Lopez AA. Determinants of performance of health systems concerning maternal and child health: a global approach. PLoS One. 2015;10(3):e0120747. doi:10.1371/journal.pone.0120747
  8. Radin D. Too ill to find the cure?: Corruption, institutions, and health care sector performance in the new democracies of Central and Eastern Europe and Former Soviet Union. East Eur Polit Soc. 2009;23(1):105-125. doi:10.1177/0888325408327850
  9. Collignon P, Athukorala PC, Senanayake S, Khan F. Antimicrobial resistance: the major contribution of poor governance and corruption to this growing problem. PLoS One. 2015;10(3):e0116746. doi:10.1371/journal.pone.0116746
  10. Gillanders R. Corruption and anxiety in Sub-Saharan Africa. Econ Gov. 2016;17(1):47-69. doi:10.1007/s10101-015-0177-6
  11. Habibov N. Effect of corruption on healthcare satisfaction in post-soviet nations: A cross-country instrumental variable analysis of twelve countries. Soc Sci Med. 2016;152:119-124. doi:10.1016/j.socscimed.2016.01.044
  12. Bullough O. How Ukraine is fighting corruption one heart stent at a time. The New York Times. September 3, 2018. https://www.nytimes.com/2018/09/03/opinion/ukraine-corruption-heart-stents-procurement.html.
  13. Hessami Z, Uebelmesser S. A political-economy perspective on social expenditures: corruption and in-kind versus cash transfers. Economics of Governance. 2016;17(1):71-100. doi:10.1007/s10101-015-0178-5
  14. VA Office of Inspector General. Veterans Health Administration Review of Alleged Patient Deaths, Patient Wait Times, and Scheduling Practices at the Phoenix VA Health Care System. Washington, DC: VA Office of Inspector General; 2014.
  15. Vian T, Gryboski K, Sinoimeri Z, Hall R. Informal payments in government health facilities in Albania: results of a qualitative study. Soc Sci Med. 2006;62(4):877-887. doi:10.1016/j.socscimed.2005.07.005
  16. Miller WL. Corruption and corruptibility. World Dev. 2006;34(2):371-380. doi:10.1016/j.worlddev.2005.03.008
  17. Azfar O, Murrell P. Identifying reticent respondents: assessing the quality of survey data on corruption and values. Econ Dev Cult Change. 2009;57(2):387-411. doi:10.1086/592840
  18. Khodamoradi A, Ghaffari MP, Daryabeygi-Khotbehsara R, Sajadi HS, Majdzadeh R. A systematic review of empirical studies on methodology and burden of informal patient payments in health systems. Int J Health Plann Manage. 2018;33(1):e26-e37. doi:10.1002/hpm.2464
  19. Remnick D. Ten days in June. The New Yorker. June 26, 2015. https://www.newyorker.com/news/news-desk/ten-days-in-june.  
  20. Bazerman MH, Tenbrunsel AE. Blind spots: Why we fail to do what’s right and what to do about it. Hoboken, NJ: Princeton University Press; 2011.
  21. Shu LL, Mazar N, Gino F, Ariely D, Bazerman MH. Signing at the beginning makes ethics salient and decreases dishonest self-reports in comparison to signing at the end. Proc Natl Acad Sci U S A. 2012;109(38):15197-15200. doi:10.1073/pnas.1209746109
  22. Wells JT. Principles of fraud examination. Hoboken, NJ: John Wiley & Sons; 2011.
  23. Paschke A, Dimancesco D, Vian T, Kohler JC, Forte G. Increasing transparency and accountability in national pharmaceutical systems. Bull World Health Organ. 2018;96(11):782-791. doi:10.2471/blt.17.206516
  24. Tunley M, Button M, Shepherd D, Blackbourn D. Preventing occupational corruption: utilising situational crime prevention techniques and theory to enhance organisational resilience. Secur J. 2018;31(1):21-52. doi:10.1057/s41284-016-0087-5
Volume 8, Issue 8
August 2019
Pages 505-507
  • Receive Date: 29 April 2019
  • Revise Date: 13 May 2019
  • Accept Date: 14 May 2019
  • First Publish Date: 01 August 2019